{"id":3602966,"date":"2022-09-29T06:45:00","date_gmt":"2022-09-29T10:45:00","guid":{"rendered":"https:\/\/www.merck.com\/news\/merck-to-hold-third-quarter-2022-sales-and-earnings-conference-call-october-27\/"},"modified":"2022-10-04T13:31:39","modified_gmt":"2022-10-04T17:31:39","slug":"merck-to-hold-third-quarter-2022-sales-and-earnings-conference-call-october-27","status":"publish","type":"news_item","link":"https:\/\/www.merck.com\/news\/merck-to-hold-third-quarter-2022-sales-and-earnings-conference-call-october-27\/","title":{"rendered":"Merck to Hold Third-Quarter 2022 Sales and Earnings Conference Call October 27"},"content":{"rendered":"<div class=\"q4default\">\n<p>    RAHWAY, N.J.&#8211;(BUSINESS WIRE)&#8211;<br \/>\nMerck (NYSE: MRK), known as MSD outside the United States and Canada, will hold its third-quarter 2022 sales and earnings conference call with institutional investors and analysts at 8:00 a.m. ET on Thursday, October 27. During the call, company executives will provide an overview of Merck\u2019s performance for the quarter and outlook.\n<\/p>\n<p>\nInvestors, journalists and the general public may access a live audio webcast of the call via this <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fonlinexperiences.com%2FLaunch%2FQReg%2FShowUUID%3D7812E214-0AD8-4F2D-BE48-79C7D7F7C541%26LangLocaleID%3D1033&amp;esheet=52929752&amp;newsitemid=20220929005282&amp;lan=en-US&amp;anchor=weblink&amp;index=1&amp;md5=6ac9d5b0b05b8d306d1c59cde4c75170\" shape=\"rect\">weblink<\/a>. A replay of the webcast, along with the sales and earnings news release, supplemental financial disclosures, and slides highlighting the results, will be available at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.merck.com&amp;esheet=52929752&amp;newsitemid=20220929005282&amp;lan=en-US&amp;anchor=www.merck.com&amp;index=2&amp;md5=9674f9f72a91446c99d78f983e679ead\" shape=\"rect\">www.merck.com<\/a>.\n<\/p>\n<p>\nParticipants may join the call by dialing (877) 692-8955 (USA Toll-Free) or (243) 720-6979 (USA Caller Paid). If you are calling from other countries, visit this <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.teleconference.att.com%2Fservlet%2FglbAccess%3Fprocess%3D1%26accessCode%3D9646315%26accessNumber%3D2347206979%26startDate%3D10%2F27%2F2022%26startTimeHr%3D08%26startTimeMin%3D00%26ampm%3DAM%26tz%3DEDT%23C2&amp;esheet=52929752&amp;newsitemid=20220929005282&amp;lan=en-US&amp;anchor=weblink&amp;index=3&amp;md5=f6da64f174fcfc90d692d0eb44dfd17b\" shape=\"rect\">weblink<\/a>. All dial-in participants can use the access code 9646315. Journalists who wish to ask questions are requested to contact a member of Merck\u2019s Media Relations team.\n<\/p>\n<p>\n  <b>About Merck<br \/>\n<br \/><\/b>At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world \u2013 and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.merck.com%2F&amp;esheet=52929752&amp;newsitemid=20220929005282&amp;lan=en-US&amp;anchor=www.merck.com&amp;index=4&amp;md5=04e9446608d4e1201768973d76e0ace5\" shape=\"rect\">www.merck.com<\/a> and connect with us on <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2FMerck&amp;esheet=52929752&amp;newsitemid=20220929005282&amp;lan=en-US&amp;anchor=Twitter&amp;index=5&amp;md5=67a77ec52922336780eb48d53d90b3a6\" shape=\"rect\">Twitter<\/a>, <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.facebook.com%2FMerckInvents%2F&amp;esheet=52929752&amp;newsitemid=20220929005282&amp;lan=en-US&amp;anchor=Facebook&amp;index=6&amp;md5=5c8cedf7c8013a5795deae0f3772e4f7\" shape=\"rect\">Facebook<\/a>, <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.instagram.com%2Fmerck%2F&amp;esheet=52929752&amp;newsitemid=20220929005282&amp;lan=en-US&amp;anchor=Instagram&amp;index=7&amp;md5=99b0be9131db4a354d73c19a87c080e5\" shape=\"rect\">Instagram<\/a>, <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.youtube.com%2FMerck&amp;esheet=52929752&amp;newsitemid=20220929005282&amp;lan=en-US&amp;anchor=YouTube&amp;index=8&amp;md5=f1f6e81aa0035fc429542fe790f07498\" shape=\"rect\">YouTube<\/a> and <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fmerck&amp;esheet=52929752&amp;newsitemid=20220929005282&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=9&amp;md5=91b1425399508e6abc4ac4ecf06a6b37\" shape=\"rect\">LinkedIn<\/a>.\n<\/p>\n<p>\n  <b>Forward-Looking Statement of Merck &amp; Co., Inc., Rahway, N.J., USA<br \/>\n<br \/><\/b>This news release of Merck &amp; Co., Inc., Rahway, N.J., USA (the \u201ccompany\u201d) includes \u201cforward-looking statements\u201d within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company\u2019s management and are subject to significant risks and uncertainties. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.\n<\/p>\n<p>\nRisks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of the global outbreak of novel coronavirus disease (COVID-19); the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company\u2019s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company\u2019s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and\/or regulatory actions.\n<\/p>\n<p>\nThe company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company\u2019s Annual Report on Form 10-K for the year ended December 31, 2021 and the company\u2019s other filings with the Securities and Exchange Commission (SEC) available at the SEC\u2019s Internet site (<a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sec.gov&amp;esheet=52929752&amp;newsitemid=20220929005282&amp;lan=en-US&amp;anchor=www.sec.gov&amp;index=10&amp;md5=85f43348990a747a87bb4b986a277dd1\" shape=\"rect\">www.sec.gov<\/a>).\n<\/p>\n<p>\n  <img alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20220929005282r1&amp;sid=acqr8&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\"><br \/>\n  <span class=\"bwct31415\"><\/span>\n<\/p>\n<p id=\"mmgallerylink\">\n  <span id=\"mmgallerylink-phrase\">View source version on <a href=\"http:\/\/businesswire.com\">businesswire.com<\/a>: <\/span><br \/>\n  <span id=\"mmgallerylink-link\"><br \/>\n    <a href=\"https:\/\/www.businesswire.com\/news\/home\/20220929005282\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20220929005282\/en\/<\/a><br \/>\n  <\/span>\n<\/p>\n<p>\nMedia:<br \/>\n<br \/>Johanna Herrmann<br \/>\n<br \/>(617) 216-6029\n<\/p>\n<p>\nMelissa Moody<br \/>\n<br \/>(215) 407-3536\n<\/p>\n<p>\nInvestors:<br \/>\n<br \/>Peter Dannenbaum<br \/>\n<br \/>(908) 740-1037\n<\/p>\n<p>\nSteven Graziano<br \/>\n<br \/>(908) 740-6582\n<\/p>\n<p>Source: Merck &amp; Co., Inc.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Merck (NYSE: MRK), known as MSD outside the United States and Canada, will hold its third-quarter 2022 sales and earnings conference call with institutional investors and analysts at 8:00 a.m. ET on Thursday, October 27. During the call, company executives will provide an overview of Merck\u2019s performance for the quarter and outlook. Investors, journalists and the general public may access a live audio webcast of the call via this weblink . A replay of the webcast, along with the sales and earnings news release, supplemental financial disclosures, and slides highlighting the results, will be available at www.merck.com . Participants may join the call by dialing (877) 692-8955 (USA Toll-Free) or (243) 720-6979 (USA Caller Paid). If you are calling from other countries, visit this weblink . All dial-in participants can use the access code 9646315. Journalists who wish to ask questions are requested to contact a member of Merck\u2019s Media Relations team. About Merck At Merck, known as MSD<\/p>\n","protected":false},"template":"","meta":{"inpsyde_pem_expiration_date":[],"inpsyde_pem_expiration_action":[],"episode_type":"","audio_file":"","duration":"","filesize":"","date_recorded":"","explicit":"","block":"","filesize_raw":""},"tags":[289],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v18.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Merck to Hold Third-Quarter 2022 Sales and Earnings Conference Call October 27 - Merck.com<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.merck.com\/news\/merck-to-hold-third-quarter-2022-sales-and-earnings-conference-call-october-27\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Merck to Hold Third-Quarter 2022 Sales and Earnings Conference Call October 27 - Merck.com\" \/>\n<meta property=\"og:description\" content=\"Merck (NYSE: MRK), known as MSD outside the United States and Canada, will hold its third-quarter 2022 sales and earnings conference call with institutional investors and analysts at 8:00 a.m. ET on Thursday, October 27. During the call, company executives will provide an overview of Merck\u2019s performance for the quarter and outlook. Investors, journalists and the general public may access a live audio webcast of the call via this weblink . A replay of the webcast, along with the sales and earnings news release, supplemental financial disclosures, and slides highlighting the results, will be available at www.merck.com . Participants may join the call by dialing (877) 692-8955 (USA Toll-Free) or (243) 720-6979 (USA Caller Paid). If you are calling from other countries, visit this weblink . All dial-in participants can use the access code 9646315. Journalists who wish to ask questions are requested to contact a member of Merck\u2019s Media Relations team. About Merck At Merck, known as MSD\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.merck.com\/news\/merck-to-hold-third-quarter-2022-sales-and-earnings-conference-call-october-27\/\" \/>\n<meta property=\"og:site_name\" content=\"Merck.com\" \/>\n<meta property=\"article:modified_time\" content=\"2022-10-04T17:31:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&#038;sty=20220929005282r1&#038;sid=acqr8&#038;distro=nx&#038;lang=en\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.merck.com\/#website\",\"url\":\"https:\/\/www.merck.com\/\",\"name\":\"Merck.com\",\"description\":\"Just another vip-msd.com site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.merck.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/www.merck.com\/news\/merck-to-hold-third-quarter-2022-sales-and-earnings-conference-call-october-27\/#primaryimage\",\"inLanguage\":\"en-US\",\"url\":\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20220929005282r1&amp;sid=acqr8&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20220929005282r1&amp;sid=acqr8&amp;distro=nx&amp;lang=en\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.merck.com\/news\/merck-to-hold-third-quarter-2022-sales-and-earnings-conference-call-october-27\/#webpage\",\"url\":\"https:\/\/www.merck.com\/news\/merck-to-hold-third-quarter-2022-sales-and-earnings-conference-call-october-27\/\",\"name\":\"Merck to Hold Third-Quarter 2022 Sales and Earnings Conference Call October 27 - Merck.com\",\"isPartOf\":{\"@id\":\"https:\/\/www.merck.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.merck.com\/news\/merck-to-hold-third-quarter-2022-sales-and-earnings-conference-call-october-27\/#primaryimage\"},\"datePublished\":\"2022-09-29T10:45:00+00:00\",\"dateModified\":\"2022-10-04T17:31:39+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.merck.com\/news\/merck-to-hold-third-quarter-2022-sales-and-earnings-conference-call-october-27\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.merck.com\/news\/merck-to-hold-third-quarter-2022-sales-and-earnings-conference-call-october-27\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.merck.com\/news\/merck-to-hold-third-quarter-2022-sales-and-earnings-conference-call-october-27\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"News\",\"item\":\"https:\/\/www.merck.com\/news-archive\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Merck to Hold Third-Quarter 2022 Sales and Earnings Conference Call October 27\"}]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Merck to Hold Third-Quarter 2022 Sales and Earnings Conference Call October 27 - Merck.com","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.merck.com\/news\/merck-to-hold-third-quarter-2022-sales-and-earnings-conference-call-october-27\/","og_locale":"en_US","og_type":"article","og_title":"Merck to Hold Third-Quarter 2022 Sales and Earnings Conference Call October 27 - Merck.com","og_description":"Merck (NYSE: MRK), known as MSD outside the United States and Canada, will hold its third-quarter 2022 sales and earnings conference call with institutional investors and analysts at 8:00 a.m. ET on Thursday, October 27. During the call, company executives will provide an overview of Merck\u2019s performance for the quarter and outlook. Investors, journalists and the general public may access a live audio webcast of the call via this weblink . A replay of the webcast, along with the sales and earnings news release, supplemental financial disclosures, and slides highlighting the results, will be available at www.merck.com . Participants may join the call by dialing (877) 692-8955 (USA Toll-Free) or (243) 720-6979 (USA Caller Paid). If you are calling from other countries, visit this weblink . All dial-in participants can use the access code 9646315. Journalists who wish to ask questions are requested to contact a member of Merck\u2019s Media Relations team. About Merck At Merck, known as MSD","og_url":"https:\/\/www.merck.com\/news\/merck-to-hold-third-quarter-2022-sales-and-earnings-conference-call-october-27\/","og_site_name":"Merck.com","article_modified_time":"2022-10-04T17:31:39+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20220929005282r1&amp;sid=acqr8&amp;distro=nx&amp;lang=en"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebSite","@id":"https:\/\/www.merck.com\/#website","url":"https:\/\/www.merck.com\/","name":"Merck.com","description":"Just another vip-msd.com site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.merck.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"ImageObject","@id":"https:\/\/www.merck.com\/news\/merck-to-hold-third-quarter-2022-sales-and-earnings-conference-call-october-27\/#primaryimage","inLanguage":"en-US","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20220929005282r1&amp;sid=acqr8&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20220929005282r1&amp;sid=acqr8&amp;distro=nx&amp;lang=en"},{"@type":"WebPage","@id":"https:\/\/www.merck.com\/news\/merck-to-hold-third-quarter-2022-sales-and-earnings-conference-call-october-27\/#webpage","url":"https:\/\/www.merck.com\/news\/merck-to-hold-third-quarter-2022-sales-and-earnings-conference-call-october-27\/","name":"Merck to Hold Third-Quarter 2022 Sales and Earnings Conference Call October 27 - Merck.com","isPartOf":{"@id":"https:\/\/www.merck.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.merck.com\/news\/merck-to-hold-third-quarter-2022-sales-and-earnings-conference-call-october-27\/#primaryimage"},"datePublished":"2022-09-29T10:45:00+00:00","dateModified":"2022-10-04T17:31:39+00:00","breadcrumb":{"@id":"https:\/\/www.merck.com\/news\/merck-to-hold-third-quarter-2022-sales-and-earnings-conference-call-october-27\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.merck.com\/news\/merck-to-hold-third-quarter-2022-sales-and-earnings-conference-call-october-27\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.merck.com\/news\/merck-to-hold-third-quarter-2022-sales-and-earnings-conference-call-october-27\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"News","item":"https:\/\/www.merck.com\/news-archive\/"},{"@type":"ListItem","position":2,"name":"Merck to Hold Third-Quarter 2022 Sales and Earnings Conference Call October 27"}]}]}},"_links":{"self":[{"href":"https:\/\/www.merck.com\/wp-json\/wp\/v2\/news_item\/3602966"}],"collection":[{"href":"https:\/\/www.merck.com\/wp-json\/wp\/v2\/news_item"}],"about":[{"href":"https:\/\/www.merck.com\/wp-json\/wp\/v2\/types\/news_item"}],"version-history":[{"count":1,"href":"https:\/\/www.merck.com\/wp-json\/wp\/v2\/news_item\/3602966\/revisions"}],"predecessor-version":[{"id":3602967,"href":"https:\/\/www.merck.com\/wp-json\/wp\/v2\/news_item\/3602966\/revisions\/3602967"}],"wp:attachment":[{"href":"https:\/\/www.merck.com\/wp-json\/wp\/v2\/media?parent=3602966"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.merck.com\/wp-json\/wp\/v2\/tags?post=3602966"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}